Specialty Drug Reimbursement Newsletter

Specialty Drug Reimbursement Newsletter | November 2026

November

10

2026

RJ Health, an MMIT company, delivers industry standard specialty drug pricing, coding and reimbursement solutions to support payer and provider alignment.

Every month, our team evaluates a variety of pricing and coding updates. In the November edition of the Specialty Drug Reimbursement Newsletter, we identified 65 drug code price changes this month, with 21 of them being price decreases. We have also identified drugs to be added or updated within our database. Preview some of these insights below:

This month, during our review of the 4254 Reimbursement HCPCS/CPT® Codes in our system, we identified 65 Drug Codes that required a recalculation of their AWP Code Price. Clients can log in to www.ReimbursementCodes.com to view the pricing updates for these codes.

A4245 J0775 J1939 J3486 J9060 S0117
A9591 J0872 J2212 J7030 J9072 S0119
B4155 J1162 J2270 J7040 J9119 S0132
B4158 J1271 J2405 J7050 J9172 S0182
J0014 J1302 J2675 J7626 J9205 S4991
J0153 J1305 J2781 J8565 J9218  
J0174 J1437 J2786 J9027 J9292  
J0175 J1448 J2860 J9028 J9395  
J0462 J1596 J3110 J9029 J9601  
J0475 J1644 J3145 J9032 Q0162  
J0687 J1747 J3245 J9041 Q5147  
J0690 J1930 J3411 J9045 Q9968  

ReimbursementCodes was designed for organizations like yours to manage pricing, coding and clinical challenges related to specialty drugs. To gain access to this tool and view the rest of the insights we captured this month, visit our site or contact marketing@mmitnetwork.com.

RJ Health Clinical Team

RJ Health Clinical Team

Featured

Rebates Take the First Hit: How MFN Pricing Is Reshaping Payer Strategy

whats-shaping-coverage-under-medicare-drug-price-negotiation

Competition, Not Discounts: What’s Shaping Coverage Under Medicare Drug Price Negotiation

glp-1s-crossroads-access-innovation

GLP-1s at a Crossroads: Access and Innovation

Stay In Touch

Be the first to know about new arrivals and promotions

NEW RELEASE: The State of Patient Access 2026